Page last updated: 2024-08-16
imatinib and luteolin
imatinib has been researched along with luteolin in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Masuda, ES; Payan, DG; Singh, R | 1 |
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
Reviews
1 review(s) available for imatinib and luteolin
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
Other Studies
1 other study(ies) available for imatinib and luteolin
| Article | Year |
|---|---|
Discovery and development of spleen tyrosine kinase (SYK) inhibitors.
Topics: Animals; Autoimmune Diseases; Drug Discovery; Enzyme Inhibitors; Humans; Hypersensitivity; Intracellular Signaling Peptides and Proteins; Mice; Protein-Tyrosine Kinases; Structure-Activity Relationship; Syk Kinase; ZAP-70 Protein-Tyrosine Kinase | 2012 |